Scholarlink

Purpose <p>To evaluate the clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis (AC) resistant to conventional treatments.</p> Materials and Methods <p>This is a retrospective analysis performed between January 2015 and December 2024. TAE was performed with a suspension of imipenem/cilastatin sodium in contrast agent. Subjects were assessed before, 1&#xa0;week, 1, 3, 6 and 12&#xa0;months after the procedure using the pain visual analogue scale (VAS) and the joint balance of Constant-Murley score (CMS). Demographic variables, risk factors, technical aspects and adverse events were also evaluated.</p> Results <p>The study included 128 TAE procedures in 118 patients with AC. 84/118 [71.7%] women; mean age 52.4 ± 8.7&#xa0;years old. One patient was lost to follow-up. Six months after TAE, significant improvements were observed in terms of pain reduction 7.8 vs. 2.2, <i>P</i> &lt; .001 and regarding mobility in flexion and abduction, respectively (90.1° vs. 143.3°, <i>P</i> &lt; .001; 79.6° vs. 128.8°, <i>P</i> &lt; .001). No major adverse events occurred. Clinical improvement was documented in 115/128 (89.8%) at 12-month follow-up.</p> Conclusions <p>TAE achieved pain reduction and functional improvement in patients with adhesive capsulitis refractory to conservative treatments.</p> Level of Evidence <p>Level 4, Case Series.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical Outcomes of Shoulder Artery Embolization for Adhesive Capsulitis

  • 期刊论文

  • 发表日期：

    2025年6月5日

查看全文
  • Ana María Fernández Martínez,
  • Patricia Cordero Carnicero,
  • Andrea Pérez Álvarez,
  • M. Teresa Cuesta Marcos,
  • David Romero Alonso,
  • Sebastián Baldi

摘要

Purpose

To evaluate the clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis (AC) resistant to conventional treatments.

Materials and Methods

This is a retrospective analysis performed between January 2015 and December 2024. TAE was performed with a suspension of imipenem/cilastatin sodium in contrast agent. Subjects were assessed before, 1 week, 1, 3, 6 and 12 months after the procedure using the pain visual analogue scale (VAS) and the joint balance of Constant-Murley score (CMS). Demographic variables, risk factors, technical aspects and adverse events were also evaluated.

Results

The study included 128 TAE procedures in 118 patients with AC. 84/118 [71.7%] women; mean age 52.4 ± 8.7 years old. One patient was lost to follow-up. Six months after TAE, significant improvements were observed in terms of pain reduction 7.8 vs. 2.2, P < .001 and regarding mobility in flexion and abduction, respectively (90.1° vs. 143.3°, P < .001; 79.6° vs. 128.8°, P < .001). No major adverse events occurred. Clinical improvement was documented in 115/128 (89.8%) at 12-month follow-up.

Conclusions

TAE achieved pain reduction and functional improvement in patients with adhesive capsulitis refractory to conservative treatments.

Level of Evidence

Level 4, Case Series.

Graphical Abstract